SOCS3 loaded EVs from AMs may play an important role in the pathogenesis of asthma and synthetic SOCS3 encapsulated liposomes treated in cells and mouse model of allergic asthma showed attenuation of cytokine release and airway inflammation, respectively[42]. Here, SOCS3 is linked to allergic asthma.